SARA KELLER: Open Payments
NPI 1124636964 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 20 payments from 6 companies in 2025. Trend: 2023 $952 · 2024 $397 · 2025 $430
Food & beverage: $396Education: $34
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $147 |
| GENZYME CORPORATION | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| ABBVIE INC. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, RINVOQ, TAVNEOS, BENLYSTA, SAPHNELO.
Industry payments across NY — which companies pay providers there.
